This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: David M Weinreich: Innovator in Renal Cell Carcinoma Treatment
Introduction
David M Weinreich is a notable inventor based in Basking Ridge, NJ (US). He has made significant contributions to the field of medical research, particularly in the treatment of renal cell carcinoma. His innovative work focuses on improving patient outcomes through predictive biomarkers.
Latest Patents
David M Weinreich holds a patent for a predictive biomarker of survival in the treatment of renal cell carcinoma. The patent outlines methods and compositions for predicting and treating the clinical benefit to a human renal cell carcinoma patient prior to their treatment with a VEGFR inhibitor and an Ang2 inhibitor. This advancement has the potential to enhance treatment efficacy and patient care.
Career Highlights
David is currently employed at Amgen Inc., a leading biotechnology company known for its focus on innovative therapies. His work at Amgen has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
One of his notable coworkers is Abraham Antonio Anderson. Together, they work on advancing the understanding and treatment of renal cell carcinoma.
Conclusion
David M Weinreich's contributions to the field of renal cell carcinoma treatment through his innovative patent demonstrate his commitment to improving patient outcomes. His work at Amgen Inc. continues to pave the way for future advancements in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile